Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 22, 1239-1245, November 1, 1962]
© 1962 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, C.
Right arrow Articles by Bauer, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, C.
Right arrow Articles by Bauer, J. M.

Catabolism of Xanthine and Uracil in Tumor-bearing Rats*

Chung Wu and Jere M. Bauer

( Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan)

The urinary excretion of allantoin and uric acid was greatly increased in rats bearing Walker carcinoma 256. The increase was greater with more advanced tumor growth. A similar increase was also observed in the allantoin concentration of the plasma and liver of these rats. An increase in the RNA and DNA content and a decrease in the RNA/DNA ratio were found in the muscle of the tumor-bearing animals. Liver xanthine oxidase activity was increased in rats bearing Walker 256 and Guerin carcinomas and Novikoff and Morris 3683 hepatomas but was unchanged in rats bearing Jensen sarcoma, Morris 5123, and Morris 3924-A hepatomas, when compared with their respective controls fed ad libitum. Liver uracil reductase activity showed a decrease in rats bearing Morris 5123 and Morris 3924-A hepatomas but no change in rats bearing Walker carcinoma 256 and Novikoff and Morris 3683 hepatomas. These findings indicate that the effect of different tumors on a given enzyme in the host system need not be qualitatively uniform. Finally, unlike the other hepatomas tested, Morris 5123 hepatoma was found to possess xanthine oxidase activity approaching that found in a normal liver.

* The work was supported in part by a research grant (C1719) from the National Cancer Institute, U.S. Public Health Service.

Received 7/ 7/62.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1962 by the American Association for Cancer Research.